References
- J Kingdon. Agendas, Alternatives, and Public Policies. 2002; Longman: New York.
- T Hafner, J Shiffman. The emergence of global attention to health systems strengthening. Health Policy and Planning. 28(1): 2013; 41–50.
- R Gregory. Political rationality or “Incrementalism”? Charles E Lindblom’s enduring contribution to public policy making theory. Policy & Politics. 17(2): 1998; 139–153. http://openurl.ingenta.com/content/xref?genre=article&issn=0305-5736&volume=17&issue=2&spage=139.
- FR Baumgartner, BD Jones. Agendas and Instability in American Politics. 1993; University of Chicago Press: Chicago.
- A Du Toit. Making sense of “evidence” — Notes of the discursive politics of research and pro-poor policy making. Working Paper 21. 2012; Institute for Poverty, Land and Agrarian Studies, University of the Western Cape: Belleville.
- B Klugman. Effective social justice advocacy: a theory-of-change framework for assessing progress. Reproductive Health Matters. 19(38): 2011; 146–162.
- RHM Blog. Comments on the report of the global thematic consultation on health submitted by Reproductive Health Matters, 19 February 2013. http://rhmatters.wordpress.com/2013/02/20/comments-on-the-report-of-the-global-thematic-consultation-on-health-submitted-by-reproductive-health-matters-19-february-2013/
- WR Lowry. Can bureaucracies change policy?. Journal of Policy History. 20: 2008; 287–306.
- Women's Global Network for Reproductive Rights. Civil society platform to promote SRHR beyond 2015. http://www.wgnrr.org/news/civil-society-platform-promote-srhr-beyond-2015
- Christenson K, Wilson R. Africa: Global Campaign for Microbicides to close by September 2012. Press release. 23 July 2012.
- AVERT. Women and HIV/AIDS. http://www.avert.org/women-hiv-aids.htm
- Z Stein. HIV prevention: the need for methods women can use. American Journal of Public Health. 80: 1990; 460–462.
- National Institutes of Health. National Conference on Women and HIV Infection: Recommendations for research on women and HIV infection. Conference Report. 1991; US Government Printing Office: Washington, DC.
- L Van Damme, G Ramjee, M Alary. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 360(9338): 2002; 971–977.
- L Heise, C Elias. Transforming AIDS prevention to meet women’s needs: a focus on developing countries. Social Science and Medicine. 40(7): 1995; 933–943.
- Global Campaign for Microbicides. Rethinking the Ethical Roadmap for Clinical Testing of Microbicides: Report on an International Consultation. 2005; PATH: Washington, DC.
- A Batson, M Ainsworth. Private investment in AIDS vaccine development: obstacles and solutions. Bulletin of the World Health Organization. 79: 2001; 721–727.
- Arias G, Jervis CA. Money, moralism and microbicides: barriers in microbicides development. GMHC Treatment Issues. January-March 2007.
- HIV Vaccines and Microbicides Tracking Working Group. Funding for HIV prevention research: Microbicides 2000–2012. 2013. http://www.hivresourcetracking.org/content/microbicides-0
- HIV Vaccines and Microbicides Tracking Working Group. Adding it all up: funding for HIV vaccine and microbicide development 2000–2005. 2006. http://www.hivresourcetracking.org/sites/default/files/RT_2006_Report_FINAL_02.pdf
- HIV Vaccines and Microbicides Tracking Working Group. Advancing the science in a time of fiscal constraint: Funding for HIV prevention technologies in 2009. 2010. http://www.hivresourcetracking.org/sites/default/files/RTWG Advancing the Science-final.pdf
- A Forbes, S Mudaliar. Preventing prevention trial failures: a case study and lessons for future trials from the 2004 tenofovir trial in Cambodia. 2009; Global Campaign for Microbicides: Washington, DC.
- A Irvin, E McGrory. Research Rashomon: lessons from the Cameroon pre-exposure prophylaxis trial site. 2009; Washington, DC: Global Campaign for Microbicides.
- HIV-Science in Action. Science in the Community. London: British Broadcasting Corporation [television broadcast]. 26 September 2007.
- HA Washington. Why Africa fears western medicine. New York Times. 31 July 2007. http://www.nytimes.com/2007/07/31/opinion/31washington.html?_r=0
- K West Slevin, M Ukpong, L Heise. Community engagement in HIV prevention trials: evolution of the field and opportunities for growth. AIDS 2013 Background Paper. 2008; Global Campaign for Microbicides: Washington DC. http://www.path.org/publications/files/aids2031_comm_engage.pdf.
- Q Abdool Karim, SS Abdool Karim, JA Frohlich. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 329: 2010; 1168–1174.
- JM Baeten, D Donnell, P Ndase. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine. 365: 2012; 399–410.
- MS Cohen, YQ Chen, M McCauley. Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine. 365: 2011; 493–505.
- J Esparza. A brief history of the global effort to develop a preventive HIV vaccine. Vaccine. 31(35): 2013; 3502–3518.
- A Forbes, S Dube, M Gottemoeller. In our own hands: a case study on mobilizing demand for HIV prevention for women. Report. 2013; PATH: Washington DC. [In press].
- L London. What is a human rights-based approach to health and does it matter?. Health and Human Rights. 10: 2008; 65–80.